Tositumomab Side Effects
Applies to tositumomab: intravenous solution.
Important warnings
This medicine can cause some serious health issues
Intravenous route (solution)
Serious Allergic Reactions: Immediately interrupt infusion and permanently discontinue the tositumomab and iodine I 131 tositumomab therapeutic regimen for serious allergic reactions.
Prolonged and severe cytopenias occur in most patients.
Tositumomab and iodine I 131 tositumomab should not be administered to patients with greater than 25% lymphoma marrow involvement, platelet count less than 100,000 cells/mm(3), or neutrophil count less than 1500 cells/mm(3).
The tositumomab and iodine I 131 tositumomab therapeutic regimen is supplied only to certified healthcare professionals.
Follow institutional radiation safety practices and applicable federal guidelines to minimize radiation exposure to household contacts and medical staff.
Intravenous route (solution)
Serious Allergic Reactions: Immediately interrupt infusion and permanently discontinue the tositumomab and iodine I 131 tositumomab therapeutic regimen for serious allergic reactions.
Prolonged and severe cytopenias occur in most patients.
Tositumomab and iodine I 131 tositumomab should not be administered to patients with greater than 25% lymphoma marrow involvement, platelet count less than 100,000 cells/mm(3), or neutrophil count less than 1500 cells/mm(3).
The tositumomab and iodine I 131 tositumomab therapeutic regimen is supplied only to certified healthcare professionals.
Follow institutional radiation safety practices and applicable federal guidelines to minimize radiation exposure to household contacts and medical staff.
Precautions
It is very important that your doctor check you closely while you are receiving this medicine. This is to make sure that this medicine is working properly. Blood tests may be needed to check for unwanted effects.
Using this medicine while you are pregnant can harm your unborn baby. Use an effective form of birth control to keep from getting pregnant. You should not become pregnant while you are receiving this medicine and for 12 months after stopping it. Male patients should also use effective contraception to prevent pregnancy while receiving this medicine and for 12 months after stopping it. Tell your doctor right away if you become pregnant while using the medicine.
This medicine may cause serious allergic reactions, including anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Call your doctor right away if you have a rash, itching, fever or chills, lightheadedness or dizziness, nausea, trouble breathing, or any swelling of your hands, face, mouth, or throat during treatment or within 48 hours receiving this medicine.
Tositumomab and iodine I 131 tositumomab regimen can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:
- Avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
- Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin.
- Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.
- Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.
- Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.
- Avoid sports or other situations where bruising or injury could occur.
While using this medicine, you may be exposed to radiation. Talk with your doctor if you have concerns about this.
This medicine may increase your risk for certain types of cancer or thyroid problems. Talk with your doctor about these risks.
While you are being treated with tositumomab and iodine I 131 tositumomab regimen, and after you stop treatment with it, do not have any immunizations (live vaccines) without your doctor's approval. Tositumomab and iodine I 131 tositumomab may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent.
If you plan to have children, talk with your doctor before using this medicine. Some men and women using this medicine have become infertile (unable to have children).
Serious side effects of tositumomab
Along with its needed effects, tositumomab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking tositumomab:
More common side effects
- bleeding gums
- bloating or swelling of the face, arms, hands, lower legs, or feet
- blurred vision
- bone pain
- chest pain
- chills
- confusion
- constipation
- cough
- coughing up blood
- depressed mood
- difficulty with breathing
- difficulty with swallowing
- dizziness
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- dry skin and hair
- fast heartbeat
- feeling cold
- fever or chills
- hair loss
- headache
- hives
- hoarseness or husky voice
- increased menstrual flow or vaginal bleeding
- itching
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- lower back or side pain
- muscle cramps and stiffness
- noisy breathing
- nosebleeds
- painful or difficult urination
- pale skin
- paralysis
- pinpoint red spots on the skin
- prolonged bleeding from cuts
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- rapid weight gain
- red or black, tarry stools
- red or dark brown urine
- shortness of breath
- skin rash
- slowed heartbeat
- sore throat
- sores, ulcers, or white spots on the lips or in the mouth
- sweating
- swollen glands
- tightness in the chest
- tingling of the hands or feet
- troubled breathing with exertion
- unusual bleeding or bruising
- unusual tiredness or weakness
- unusual weight gain or loss
- wheezing
Less common side effects
- feeling of warmth or heat
- flushing or redness of the skin, especially on the face and neck
Other side effects of tositumomab
Some side effects of tositumomab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- acid or sour stomach
- back pain
- belching
- body aches or pain
- congestion
- diarrhea or increased bowel movements
- difficult or labored breathing
- difficulty with moving
- dryness or soreness of the throat
- heartburn
- indigestion
- itching skin
- joint pain
- lack or loss of strength
- loose or liquid stools
- loss of appetite
- muscle aches or pains
- nausea or feeling of upset stomach or feeling like you may vomit
- neck pain
- runny nose
- stomach discomfort, upset, or pain
- sudden sweating
- swelling of the hands, ankles, feet, or lower legs
- swollen joints
- tender, swollen glands in the neck
- trouble with swallowing
- voice changes
- vomiting
- weight loss
Less common side effects
- sleepiness or unusual drowsiness
For healthcare professionals
Applies to tositumomab: intravenous kit.
Cardiovascular adverse events
- Common (1% to 10%): Hypotension, vasodilation[Ref]
Dermatologic
Endocrine
- Common (1% to 10%): Hypothyroidism[Ref]
Gastrointestinal
- Very common (10% or more): Abdominal pain, nausea, vomiting, diarrhea, anorexia
- Common (1% to 10%): Constipation, dyspepsia[Ref]
Hematologic
- Very common (10% or more): Neutropenia, thrombocytopenia, anemia[Ref]
Hypersensitivity
- Common (1% to 10%): Allergic (hypersensitivity) reactions (allergic reaction, facial edema, injection site hypersensitivity, anaphylactic reaction, laryngismus, serum sickness)
- Postmarketing reports: Hypersensitivity reactions including fatal anaphylaxis[Ref]
Immunologic
- Very common (10% or more): Positive serology for human anti-mouse antibodies (HAMA)[Ref]
Local
- Frequency not reported: Infusion reactions[Ref]
Metabolic
- Common (1% to 10%): Peripheral edema, weight loss[Ref]
Musculoskeletal
- Very common (10% or more): Myalgia, arthralgia
- Common (1% to 10%): Back pain, neck pain[Ref]
Nervous system
- Common (1% to 10%): Dizziness, somnolence
- Postmarketing reports: Axonal neuropathy leading to quadriparesis[Ref]
Oncologic
- Common (1% to 10%): Secondary malignancies (non-melanoma skin, colorectal, head and neck, breast, lung, bladder, melanoma, gastric)
- Frequency not reported: Secondary leukemia, myelodysplastic syndrome[Ref]
Other
- Very common (10% or more): Asthenia, fever, infections, pain, chills, headache
- Common (1% to 10%): Chest pain, serious infections (pneumonia, bacteremia, septicemia, bronchitis, skin infections)[Ref]
Respiratory
- Very common (10% or more): Cough, pharyngitis, dyspnea, rhinitis
- Common (1% to 10%): Pneumonia[Ref]
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Rituximab
Rituximab infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Lexiscan
Lexiscan is used as a pharmacologic stress agent in radionuclide myocardial perfusion imaging ...
Baqsimi
Baqsimi is used to treat very low blood sugar (severe hypoglycemia) in adults and children aged 1 ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Gvoke
Gvoke injection is used to treat severe hypoglycemia (low blood sugar) in patients with diabetes ...
Bendamustine
Bendamustine systemic is used for chronic lymphocytic leukemia, multiple myeloma, non-hodgkin's lymphoma
Fludarabine
Fludarabine systemic is used for cancer, chronic lymphocytic leukemia, chronic myelogenous ...
References
1. (2022) "Product Information. Bexxar I 131 Therapeutic (iodine I 131 tositumomab)." GlaxoSmithKline
2. (2006) "Product Information. BexxarTherapy (tositumomab)." GlaxoSmithKline Inc
More about tositumomab
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
Related treatment guides
Further information
Tositumomab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.